These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34777603)

  • 1. Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment.
    Soepriatna AH; Kim TY; Daley MC; Song E; Choi BR; Coulombe KLK
    Cell Mol Bioeng; 2021 Oct; 14(5):441-457. PubMed ID: 34777603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action potential metrics and automated data analysis pipeline for cardiotoxicity testing using optically mapped hiPSC-derived 3D cardiac microtissues.
    Soepriatna AH; Navarrete-Welton A; Kim TY; Daley MC; Bronk P; Kofron CM; Mende U; Coulombe KLK; Choi BR
    PLoS One; 2023; 18(2):e0280406. PubMed ID: 36745602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrarapid Delayed Rectifier K
    Hilderink S; Devalla HD; Bosch L; Wilders R; Verkerk AO
    Front Cell Dev Biol; 2020; 8():536. PubMed ID: 32850774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3-D human model of complex cardiac arrhythmias.
    Williams K; Liang T; Massé S; Khan S; Hatkar R; Keller G; Nanthakumar K; Nunes SS
    Acta Biomater; 2021 Sep; 132():149-161. PubMed ID: 33713861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug screening platform using human induced pluripotent stem cell-derived atrial cardiomyocytes and optical mapping.
    Gunawan MG; Sangha SS; Shafaattalab S; Lin E; Heims-Waldron DA; Bezzerides VJ; Laksman Z; Tibbits GF
    Stem Cells Transl Med; 2021 Jan; 10(1):68-82. PubMed ID: 32927497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome.
    Shiti A; Arbil G; Shaheen N; Huber I; Setter N; Gepstein L
    J Mol Cell Cardiol; 2023 Oct; 183():42-53. PubMed ID: 37579942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geometrical Patterning and Constituent Cell Heterogeneity Facilitate Electrical Conduction Disturbances in a Human Induced Pluripotent Stem Cell-Based Platform: An
    Nakanishi H; Lee JK; Miwa K; Masuyama K; Yasutake H; Li J; Tomoyama S; Honda Y; Deguchi J; Tsujimoto S; Hidaka K; Miyagawa S; Sawa Y; Komuro I; Sakata Y
    Front Physiol; 2019; 10():818. PubMed ID: 31316396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
    Shinnawi R; Shaheen N; Huber I; Shiti A; Arbel G; Gepstein A; Ballan N; Setter N; Tijsen AJ; Borggrefe M; Gepstein L
    J Am Coll Cardiol; 2019 May; 73(18):2310-2324. PubMed ID: 31072576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmia Assessment in Heterotypic Human Cardiac Myocyte-Fibroblast Microtissues.
    Kofron CM; Choi BR; Coulombe KLK
    Methods Mol Biol; 2022; 2485():147-157. PubMed ID: 35618904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.
    Bai S; Pei J; Chen K; Zhao Y; Cao H; Tian L; Ma Y; Dong H
    SLAS Discov; 2021 Mar; 26(3):364-372. PubMed ID: 32914673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Subtype-Specific Modeling of K
    Marczenke M; Piccini I; Mengarelli I; Fell J; Röpke A; Seebohm G; Verkerk AO; Greber B
    Front Physiol; 2017; 8():469. PubMed ID: 28729840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a Microencapsulated 3D hiPSC-Derived
    Abecasis B; Canhão PGM; Almeida HV; Calmeiro T; Fortunato E; Gomes-Alves P; Serra M; Alves PM
    Front Bioeng Biotechnol; 2020; 8():580744. PubMed ID: 33224931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp.
    Verkerk AO; Veerman CC; Zegers JG; Mengarelli I; Bezzina CR; Wilders R
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
    Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes.
    Altomare C; Bartolucci C; Sala L; Balbi C; Burrello J; Pietrogiovanna N; Burrello A; Bolis S; Panella S; Arici M; Krause R; Rocchetti M; Severi S; Barile L
    Commun Biol; 2023 Mar; 6(1):291. PubMed ID: 36934210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput optical action potential recordings in hiPSC-derived cardiomyocytes with a genetically encoded voltage indicator in the
    Zhang F; Meier AB; Poch CM; Tian Q; Engelhardt S; Sinnecker D; Lipp P; Laugwitz KL; Moretti A; Dorn T
    Front Cell Dev Biol; 2022; 10():1038867. PubMed ID: 36274846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Electrical Stimulation on hiPSC-CM Responses to Classic Ion Channel Blockers.
    Wei F; Pourrier M; Strauss DG; Stockbridge N; Pang L
    Toxicol Sci; 2020 Apr; 174(2):254-265. PubMed ID: 32040191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.
    Devalla HD; Schwach V; Ford JW; Milnes JT; El-Haou S; Jackson C; Gkatzis K; Elliott DA; Chuva de Sousa Lopes SM; Mummery CL; Verkerk AO; Passier R
    EMBO Mol Med; 2015 Apr; 7(4):394-410. PubMed ID: 25700171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myosin light chain 2 marks differentiating ventricular cardiomyocytes derived from human embryonic stem cells.
    Luo XL; Zhang P; Liu X; Huang S; Rao SL; Ding Q; Yang HT
    Pflugers Arch; 2021 Jul; 473(7):991-1007. PubMed ID: 34031754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.